AQST AQUESTIVE THERAPEUTICS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 11 analyst firms say about AQUESTIVE THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
10 rated views · 11 analyst/firm records · 11 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 5 reports on AQST from 4 analyst firms in the last 90 days (11 firms in the past year).
Comparing each firm's latest target with its previous one: 2 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Alliance Global Partners | James Molloy | Buy | 5 Mar 2026 | 9.00 USD |
| Cantor Fitzgerald | Kristen Kluska | Buy | 15 Jun 2026 | 11.00 USD |
| Citizens JMP | Jason N Butler | Buy | 6 Mar 2026 | 10.00 USD |
| H.C. Wainwright | Raghuram Selvaraju | Buy | 16 Oct 2026 | 10.00 USD |
| Lake Street Capital Markets | Thomas Flaten | Buy | 9 Jan 2026 | 6.00 USD |
| Leerink Partners | Roanna Ruiz | Buy | 10 Aug 2026 | 11.00 USD |
| Lifesci Capital | Francois Brisebois | Buy | 15 May 2026 | 9.00 USD |
| Oppenheimer | Unnamed analyst | Buy | 24 Apr 2026 | 8.00 USD |
| Piper Sandler | David Amsellem | Buy | 14 May 2026 | 8.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:13 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.